The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts

被引:509
作者
Peinado, Hector [1 ,2 ]
Lavotshkin, Simon [1 ,2 ,3 ]
Lyden, David [1 ,2 ]
机构
[1] Weill Cornell Med Coll, Dept Pediat, New York, NY 10021 USA
[2] Champalimaud Metastasis Programme, Lisbon, Portugal
[3] Maimonides Hosp, Dept Surg, New York, NY 11219 USA
关键词
Pre-metastatic niche; Exosomes; Microvesicles; Tumor; Metastasis; Bone marrow-derived cells; Bone marrow progenitor cells; TUMOR-DERIVED MICROVESICLES; PROGENITOR CELLS CORRELATE; SUPPRESSOR-CELLS; TIE2-EXPRESSING MONOCYTES; RELEASED MICROVESICLES; HORIZONTAL TRANSFER; GENE-EXPRESSION; MESSENGER-RNA; MYELOID CELLS; LYSYL OXIDASE;
D O I
10.1016/j.semcancer.2011.01.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis is a multistep process that requires acquisition of malignant cell phenotypes which allow tumor cells to escape from the primary tumor site. Each of the steps during metastatic progression involves co-evolution of the tumor and its microenvironment. Although tumor cells are the driving force of metastasis, new findings suggest that the host cells within the tumor microenvironment play a key role in influencing metastatic behavior. Many of these contributing cells are derived from the bone marrow; in particular, recruited bone marrow progenitor cells generate the "pre-metastatic niche" to which the tumor cells metastasize. Analysis of the molecular mechanisms involved in pre-metastatic niche formation has revealed that secreted soluble factors are key players in bone marrow cell mobilization during metastasis. In addition, membrane vesicles derived from both tumor and host cells have recently been recognized as new candidates with important roles in the promotion of tumor growth and metastasis. This review describes old ideas and presents new insights into the role of tumor and bone marrow-derived microvesicles and exosomes in pre-metastatic niche formation and metastasis. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 88 条
[1]   Intercellular transfer of the oncogenic receptor EGFrvIII by microvesicles derived from tumour cells [J].
Al-Nedawi, Khalid ;
Meehan, Brian ;
Micallef, Johann ;
Lhotak, Vladimir ;
May, Linda ;
Guha, Abhijit ;
Rak, Janusz .
NATURE CELL BIOLOGY, 2008, 10 (05) :619-U24
[2]   Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR [J].
Al-Nedawi, Khalid ;
Meehan, Brian ;
Kerbel, Robert S. ;
Allison, Anthony C. ;
Rak, Janusz .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) :3794-3799
[3]   Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: A novel mechanism for phenotype modulation [J].
Aliotta, Jason M. ;
Sanchez-Guijo, Fermin M. ;
Dooner, Gerri J. ;
Johnson, Kevin W. ;
Dooner, Mark S. ;
Greer, Kenneth A. ;
Greer, Deborah ;
Pimentel, Jeffrey ;
Kolankiewicz, Lutz M. ;
Puente, Napoleon ;
Faradyan, Sam ;
Ferland, Paulette ;
Bearer, Elaine L. ;
Passero, Michael A. ;
Adedi, Mehrdad ;
Colvin, Geralt A. ;
Quesenberry, Peter J. .
STEM CELLS, 2007, 25 (09) :2245-2256
[4]   Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription [J].
Aliotta, Jason M. ;
Pereira, Mandy ;
Johnson, Kevin W. ;
de Paz, Nicole ;
Dooner, Mark S. ;
Puente, Napoleon ;
Ayala, Carol ;
Brilliant, Kate ;
Berz, David ;
Lee, David ;
Ramratnam, Bharat ;
McMillan, Paul N. ;
Hixson, Douglas C. ;
Josic, Djuro ;
Quesenberry, Peter J. .
EXPERIMENTAL HEMATOLOGY, 2010, 38 (03) :233-245
[5]   Malignant effusions and immunogenic tumour-derived exosomes [J].
Andre, F ;
Schartz, NEC ;
Movassagh, M ;
Flament, C ;
Pautier, P ;
Morice, P ;
Pomel, C ;
Lhomme, C ;
Escudier, B ;
Le Chevalier, T ;
Tursz, T ;
Amigorena, S ;
Raposo, G ;
Angevin, E ;
Zitvogel, L .
LANCET, 2002, 360 (9329) :295-305
[6]   Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles [J].
Andreola, G ;
Rivoltini, L ;
Castelli, C ;
Huber, V ;
Perego, P ;
Deho, P ;
Squarcina, P ;
Accornero, P ;
Lozupone, F ;
Lugini, L ;
Stringaro, A ;
Molinari, A ;
Arancia, G ;
Gentile, M ;
Parmiani, G ;
Fais, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (10) :1303-1316
[7]   S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast [J].
Arai, Kazumori ;
Takano, Sachiko ;
Teratani, Takumi ;
Ito, Yasuhiro ;
Yamada, Toshihiro ;
Nozawa, Ryushi .
CURRENT CANCER DRUG TARGETS, 2008, 8 (04) :243-252
[8]   Anti-Flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis [J].
Bae, DG ;
Kim, TD ;
Li, G ;
Yoon, WH ;
Chae, CB .
CLINICAL CANCER RESEARCH, 2005, 11 (07) :2651-2661
[9]   Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes [J].
Baj-Krzyworzeka, M ;
Szatanek, R ;
Weglarczyk, K ;
Baran, J ;
Urbanowicz, B ;
Branski, P ;
Ratajczak, MZ ;
Zembala, M .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (07) :808-818
[10]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550